Francesco Gambino

Francesco Gambino

Auto-generated profile, based on publicly available information

Francesco Gambino

Donostia International Physics Center

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2024 in ChemCatChem
Verified
Journal Article
Closed access
ACAna C. Carrasco
Ana C. Carrasco
GBGreta Bajetto
Greta Bajetto
SSStefano Scoditti
Stefano Scoditti
GPGerman E. Pieslinger
German E. Pieslinger
FGFrancesco Gambino
Francesco Gambino
LSLuca Salassa
Luca Salassa

16 August 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
ACAna C. Carrasco
Ana C. Carrasco
GBGreta Bajetto
Greta Bajetto
SSStefano Scoditti
Stefano Scoditti
GPGerman E. Pieslinger
German E. Pieslinger
FGFrancesco Gambino
Francesco Gambino
LSLuca Salassa
Luca Salassa
Catalysis-based approaches offer versatile strategies for activating anticancer prodrugs, potentially allowing precise control over drug release and localization within tumor tissues, while reducing systemic toxicity. In this study, we explore the role of the phenothiazine dye methylene blue (MB+) as a photocatalyst in conjunction with biologically relevant electron donors to facilitate the red-light conversion of two Pt(IV) complexes, denoted as cis,cis,trans-[PtCl2(NH3)2(O2CCH2CH2COOH)2] (1) and trans-[Pt(O2CCH2CH2COOH)21R,2R-(DACH)(ox)] (2), into cisplatin and oxaliplatin, respectively. Combining spectroscopic techniques (NMR, UV-Vis, flash photolysis) with computational methods, we reveal that the doubly reduced MB+ (leucomethylene blue, LMB) triggers the reductive elimination of axial ligands in the two Pt(IV) precursors, generating the corresponding Pt(II) anticancer drugs. In vitro experiments conducted on the human cervical cancer cell line CaSki, which harbors multiple copies of the integrated HPV-16 genome, and on non-tumoral cells (HaCat) demonstrate that co-administration with Pt(IV) prodrugs improves MB+'s antiproliferative efficacy in cancer cells, particularly under red light exposure. This enhancement could be attributed to the catalytic production of Pt(II) species within the cellular environment.

27 April 2026 in Chemical Communications
Verified
Journal Article
Open access
PDF file
VSVladislav Y. Shevtsov
Vladislav Y. Shevtsov
FGFrancesco Gambino
Francesco Gambino
DNDaniil R. Nosov
Daniil R. Nosov
JGJerome Guillot
Jerome Guillot
SPSilvia Porporato
Silvia Porporato
ASAlexander S. Shaplov
Alexander S. Shaplov
Asymmetric thioether-TFSI Li salts plasticize PEO SPEs, suppress crystallinity, and retain conductivity, Li + transference, and stability. They also passivate Al, improving Li-metal compatibility and enabling stable Li∥LiFePO 4 cycling.